If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Directorate Change

3 Jul 2020 16:09

RNS Number : 0368S
Calculus VCT PLC
03 July 2020
 

3 July 2020

 

Calculus VCT plc

 

Directorship change

After 9 years of service, Kate Cornish-Bowden has stepped down from the Board of the Company following today's annual general meeting. The Board would like to thank Kate for her invaluable contribution as a member of the Board and Chair of the Audit Committee.

The Board are pleased to announce that Janine Nicholls has been appointed to join the Board as a non-executive director, effective 3 July 2020. Janine will also Chair the Audit Committee. Janine is a chartered accountant with over 20 years' experience in private equity across investment, operations and governance roles.

There is no information required to be disclosed pursuant to sections LR 9.6.11, LR 9.6.12 and LR 9.6.13 of the Listing Rules.

Calculus Capital Limited

Company Secretary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOARJMATMTMMBRM
Date   Source Headline
11th Sep 202012:03 pmRNSIssue of Equity - Amendment
8th Sep 20201:01 pmRNSPublication of a Prospectus
8th Sep 202012:51 pmRNSPublication of a Prospectus
3rd Sep 20202:46 pmRNSIssue of Equity
31st Jul 202012:46 pmRNSDirector/ PDMR shareholding
3rd Jul 20204:42 pmRNSResult of AGM
3rd Jul 20204:09 pmRNSDirectorate Change
18th Jun 20204:45 pmRNSTransaction in Own Shares
17th Jun 20205:34 pmRNSNet Asset Value 31 May 2020
17th Jun 20205:07 pmRNSNet Asset Value 31 May 2020
27th May 20203:40 pmRNSAnnual Financial Report
21st May 20204:09 pmRNSDirector Declaration
3rd Apr 20204:15 pmRNSIssue of Equity
31st Mar 20202:18 pmRNSNet Asset Value(s) and Impact of Covid-19
19th Dec 20194:22 pmRNSNet Asset Value(s)
12th Dec 201911:29 amRNSIssue of Equity and Correction
18th Oct 20194:40 pmRNSHalf-year Report
24th Sep 20192:18 pmRNSPublication of a Prospectus
6th Sep 201911:22 amRNSIssue of Equity
4th Sep 20193:20 pmRNSNet Asset Value(s)
31st Jul 20192:48 pmRNSTransaction in Own Shares
4th Jul 20194:24 pmRNSResult of AGM
26th Jun 20192:25 pmRNSIssue of Equity
14th Jun 20199:52 amRNSNet Asset Value(s)
9th May 20195:49 pmRNSAnnual Financial Report - Replacement
9th May 20194:12 pmRNSAnnual Financial Report
5th Apr 20193:49 pmRNSIssue of Equity
28th Feb 201910:41 amRNSIssue of Equity
22nd Feb 20194:46 pmRNSNet Asset Value(s)
4th Feb 201910:02 amRNSDirectorate Change
24th Jan 201910:19 amRNSHolding(s) in Company
23rd Jan 201912:46 pmRNSIssue of Equity
16th Jan 20192:45 pmRNSNet Asset Value(s)
8th Jan 20193:49 pmRNSNet Asset Value(s)
18th Dec 201812:42 pmRNSDirector Declaration
13th Dec 20183:34 pmRNSDirectorate Change
6th Nov 201810:17 amRNSTransaction in Own Shares
23rd Oct 20184:32 pmRNSHalf-year Report
9th Oct 20183:21 pmRNSGM Statement
17th Sep 20184:33 pmRNSHolding(s) in Company
17th Sep 20184:33 pmRNSHolding(s) in Company
14th Sep 20187:00 amRNSPublication of a Prospectus
22nd Aug 20189:24 amRNSDirector Declaration
21st Aug 20184:54 pmRNSTransaction in Own Shares
16th Aug 20183:32 pmRNSNet Asset Value(s)
2nd Aug 20181:31 pmRNSIssue of Equity
19th Jul 20184:32 pmRNSNet Asset Value(s)
3rd Jul 201812:21 pmRNSResult of Meeting & Offer for subscription
19th Jun 20183:38 pmRNSNet Asset Value(s)
22nd May 20184:52 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.